信达生物上半年期内利润8.34亿元，同比扭亏为盈

Core Viewpoint - In the first half of the year, the company achieved significant revenue growth and profitability, marking a turnaround from previous losses [1] Financial Performance - The company reported a revenue of approximately 5.953 billion yuan, representing a year-on-year increase of 50.6% [1] - The profit for the period was approximately 834 million yuan, indicating a return to profitability compared to previous losses [1] Growth Drivers - The primary factors driving the turnaround to profitability include strong revenue growth and improved operational efficiency [1]